TrialPanorama/TrialPanorama-database huggingface dataset:
Study 31006809 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 31008509 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 31009130 — Pharmacodynamic Biomarker (PDY): Antidrug antibody
Study 31010300 — Surrogate Endpoint (SUR): Blood pressure
Study 31010434 — Predictive Biomarker (PRD): GUCY2C mRNA
Genes: GUCY2C; GUC2C; STAR
Study 31011207 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 31012962 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 31014072 — Safety Biomarker (SAF): ACE
Genes: ACE1; CD143
Study 31014072 — Surrogate Endpoint (SUR): Blood pressure
Study 31014330 — Predictive Biomarker (PRD): SELENBP1 mRNA
Genes: SELENBP1; SBP
Study 31014330 — Surrogate Endpoint (SUR): Blood pressure
Study 31014395 — Predictive Biomarker (PRD): STIM1 mRNA
Genes: STIM1; GOK
Study 31014395 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study 31014683 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 31014695 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study 31015207 — Safety Biomarker (SAF): Reactive oxygen species
Study 31015344 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 31016030 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 31016233 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 31016412 — Predictive Biomarker (PRD): TF mRNA
Genes: TF; PRO1400
Study 31016505 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 31016505 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 31016505 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 31018069 — Predictive Biomarker (PRD): IL3RA mRNA
Genes: IL3RA; IL3R
Study 31018667 — Predictive Biomarker (PRD): PEAR1 mRNA
Genes: PEAR1; MEGF12
Study 31018667 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 31019170 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 31020361 — Pharmacodynamic Biomarker (PDY): Human leukocyte antigen DR
Study 31020361 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study 31020630 — Pharmacodynamic Biomarker (PDY): Heat pain threshold
Study 31023296 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study 31023296 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study 31023296 — Surrogate Endpoint (SUR): Bone mineral density
Study 31023377 — Surrogate Endpoint (SUR): Blood pressure
Study 31023700 — Predictive Biomarker (PRD): Chromosome 17p
Study 31024007 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 31024734 — Safety Biomarker (SAF): Hyaluronic acid
Study 31025953 — Predictive Biomarker (PRD): MAL mRNA
Genes: MAL
Study 31027916 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 31027916 — Predictive Biomarker (PRD): CDKN2A mRNA
Genes: CDKN2A; CDKN2; MTS1
Study 31027916 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 31027916 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study 31027916 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 31027916 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 31028506 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 31028506 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study 31028506 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study 31028664 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study 31028664 — Predictive Biomarker (PRD): IDH2 mRNA
Genes: IDH2
Study 31028664 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 31028664 — Pharmacodynamic Biomarker (PDY): 2-hydroxyglutarate
Study 31029086 — Predictive Biomarker (PRD): ACR mRNA
Genes: ACR; ACRS
Study 31033194 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 31033623 — Predictive Biomarker (PRD): EED mRNA
Genes: EED
Study 31036879 — Predictive Biomarker (PRD): TNFRSF18 mRNA
Genes: TNFRSF18; AITR; GITR; UNQ319/PRO364
Study 31037275 — Surrogate Endpoint (SUR): Serum uric acid
Study 31038469 — Surrogate Endpoint (SUR): Blood pressure
Study 31038781 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 31039409 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study 31039789 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 31039789 — Surrogate Endpoint (SUR): Blood pressure
Study 31039807 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 31040126 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 31040126 — Predictive Biomarker (PRD): ANG mRNA
Genes: ANG; RNASE5
Study 31040256 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 31040791 — Predictive Biomarker (PRD): REM1 mRNA
Genes: REM1; GES; REM
Study 31042669 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 31042669 — Safety Biomarker (SAF): Interleukin 1
Study 31042825 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study 31043157 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 31043390 — Predictive Biomarker (PRD): VDR mRNA
Genes: VDR; NR1I1
Study 31043539 — Surrogate Endpoint (SUR): Forced vital capacity
Study 31045222 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 31045222 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 31045222 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 31046124 — Safety Biomarker (SAF): Beta-2-microglobulin
Genes: B2M; CDABP0092; HDCMA22P
Study 31046124 — Predictive Biomarker (PRD): PPIA mRNA
Genes: PPIA; CYPA
Study 31046124 — Monitoring Biomarker (MOI): Cell-free DNA
Study 31046124 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 31046714 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 31046743 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 31046839 — Predictive Biomarker (PRD): IFIH1 mRNA
Genes: IFIH1; MDA5; RH116
Study 31046839 — Predictive Biomarker (PRD): DIRAS1 mRNA
Genes: DIRAS1; GBTS1; RIG
Study 31046839 — Predictive Biomarker (PRD): TNFRSF9 mRNA
Genes: TNFRSF9; CD137; ILA
Study 31046839 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 31047115 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 31048330 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 31050691 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 31050919 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 31050919 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 31050919 — Predictive Biomarker (PRD): Hormone receptor
Study 31053156 — Monitoring Biomarker (MOI): Heme oxygenase 1
Genes: HMOX1; HO; HO1
Study 31053174 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 31053538 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study 31055187 — Predictive Biomarker (PRD): VIP mRNA
Genes: VIP
Study 31055613 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 31055613 — Predictive Biomarker (PRD): TF mRNA
Genes: TF; PRO1400
Study 31057004 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 31057616 — Predictive Biomarker (PRD): SLN mRNA
Genes: SLN
Study 31057971 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 31060562 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 31060562 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 31060612 — Predictive Biomarker (PRD): TLR9
Genes: CD289
Study 31061061 — Predictive Biomarker (PRD): ABO mRNA
Genes: ABO
Study 31061070 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study 31061681 — Predictive Biomarker (PRD): TIMP2 mRNA
Genes: TIMP2
Study 31061681 — Predictive Biomarker (PRD): IGFBP7 mRNA
Genes: IGFBP7; MAC25; PSF
Study 31061876 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study 31062234 — Predictive Biomarker (PRD): CRH mRNA
Genes: CRH
Study 31062760 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 31063537 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 31063862 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 31063862 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 31064781 — Predictive Biomarker (PRD): MSLN mRNA
Genes: MSLN; MPF
Study 31064851 — Predictive Biomarker (PRD): CDK7 mRNA
Genes: CDK7; CAK; CAK1; CDKN7; MO15; STK1
Study 31066873 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 31067015 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 31067015 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 31067015 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 31067240 — Predictive Biomarker (PRD): CFH mRNA
Genes: CFH; HF; HF1; HF2
Study 31068222 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 31070470 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study 31070470 — Surrogate Endpoint (SUR): Blood pressure
Study 31070711 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study 31070733 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study 31071684 — Predictive Biomarker (PRD): COMP mRNA
Genes: COMP
Study 31074004 — Monitoring Biomarker (MOI): Tissue transglutaminase
Genes: TGM2
Study 31074220 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 31075618 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study 31075618 — Monitoring Biomarker (MOI): Procalcitonin
Study 31075727 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 31075727 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 31075769 — Predictive Biomarker (PRD): IDE mRNA
Genes: IDE
Study 31075769 — Predictive Biomarker (PRD): CDA mRNA
Genes: CDA; CDD
Study 31077039 — Predictive Biomarker (PRD): ABCD1 mRNA
Genes: ABCD1; ALD
Study 31077039 — Predictive Biomarker (PRD): AMN mRNA
Genes: AMN; UNQ513/PRO1028
Study 31077039 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 31077265 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 31077821 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 31079357 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 31082665 — Surrogate Endpoint (SUR): Blood pressure
Study 31084924 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study 31084936 — Predictive Biomarker (PRD): IDS mRNA
Genes: IDS; SIDS
Study 31085763 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 31085945 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 31086307 — Safety Biomarker (SAF): Lysosomal alpha-glucosidase
Genes: GAA
Study 31087226 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 31087382 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 31087772 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study 31088152 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study 31088560 — Predictive Biomarker (PRD): LRIT1 mRNA
Genes: LRIT1; LRRC21; PAL
Study 31088809 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study 31088831 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor receptor
Study 31090044 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 31092203 — Predictive Biomarker (PRD): AHR mRNA
Genes: AHR; BHLHE76
Study 31092713 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study 31092732 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 31092732 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 31093541 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 31093541 — Pharmacodynamic Biomarker (PDY): Cathepsin S
Genes: CTSS
Study 31093541 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study 31093566 — Surrogate Endpoint (SUR): Blood pressure
Study 31093598 — Predictive Biomarker (PRD): FGF21 mRNA
Genes: FGF21; UNQ3115/PRO10196
Study 31094744 — Surrogate Endpoint (SUR): Blood pressure
Study 31094790 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 31095282 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study 31095282 — Surrogate Endpoint (SUR): Blood pressure
Study 31095438 — Predictive Biomarker (PRD): BPIFA1 mRNA
Genes: BPIFA1; LUNX; NASG; PLUNC; SPLUNC1; SPURT; UNQ787/PRO1606
Study 31095438 — Predictive Biomarker (PRD): BPIFA2 mRNA
Genes: BPIFA2; C20orf70; SPLUNC2; UNQ510/PRO1025
Study 31097627 — Pharmacodynamic Biomarker (PDY): Stromal cell-derived factor 1
Genes: CXCL12; SDF1; SDF1A; SDF1B
Study 31097627 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study 31097627 — Predictive Biomarker (PRD): ACKR3 mRNA
Genes: ACKR3; CMKOR1; CXCR7; GPR159; RDC1
Study 31099252 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study 31099895 — Predictive Biomarker (PRD): CYP1A2 mRNA
Genes: CYP1A2
Study 31099895 — Predictive Biomarker (PRD): CYP2B6 mRNA
Genes: CYP2B6
Study 31099895 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study 31099895 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 31099895 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study 31099895 — Predictive Biomarker (PRD): CYP2E1 mRNA
Genes: CYP2E1; CYP2E
Study 31099895 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 31099895 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 31100122 — Safety Biomarker (SAF): Hemoglobin scavenger receptor
Genes: CD163; M130
Study 31100122 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 31100122 — Predictive Biomarker (PRD): FCGR3B
Genes: CD16; CD16b; FcgammaRIIIb; FcRIIIb
Study 31100122 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): CCR2 mRNA
Genes: CCR2; CMKBR2
Study 31100456 — Predictive Biomarker (PRD): CTLA4
Genes: CD152; CD; GSE; CTLA-4
Study 31101577 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 31103027 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 31104495 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 31104495 — Surrogate Endpoint (SUR): Blood pressure
Study 31104545 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 31104850 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 31106841 — Predictive Biomarker (PRD): GLS mRNA
Genes: GLS; GLS1; KIAA0838
Study 31107300 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 31107869 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 31108325 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study 31108325 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 31108325 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 31110096 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 31110096 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study 31110479 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 31111072 — Safety Biomarker (SAF): Interleukin 1
Study 31111762 — Predictive Biomarker (PRD): PAFAH1B1 mRNA
Genes: PAFAH1B1; LIS1; MDCR; MDS; PAFAHA
Study 31111762 — Predictive Biomarker (PRD): PRSS27 mRNA
Genes: PRSS27; MPN; UNQ1884/PRO4327
Study 31111867 — Surrogate Endpoint (SUR): Blood pressure
Study 31112005 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 31112005 — Surrogate Endpoint (SUR): Blood pressure
Study 31112005 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 31112005 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 31112389 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study 31112476 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 31113837 — Predictive Biomarker (PRD): CPOX mRNA
Genes: CPOX; CPO; CPX
Study 31116158 — Surrogate Endpoint (SUR): Blood pressure
Study 31116405 — Safety Biomarker (SAF): Ornithine transcarbamylase
Genes: OTC
Study 31118108 — Predictive Biomarker (PRD): DRD2 mRNA
Genes: DRD2
Study 31118445 — Surrogate Endpoint (SUR): Blood pressure
Study 31118445 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 31119471 — Safety Biomarker (SAF): Myeloperoxidase
Genes: MPO
Study 31119471 — Monitoring Biomarker (MOI): Cell-free DNA
Study 31120355 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study 31120355 — Predictive Biomarker (PRD): CCND1
Genes: U21B31
Study 31121167 — Predictive Biomarker (PRD): SERPINA1 mRNA
Genes: SERPINA1; AAT; PI; PRO0684; PRO2209
Study 31121167 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 31121319 — Predictive Biomarker (PRD): TCF7L2 mRNA
Genes: TCF7L2; TCF4
Study 31122221 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study 31122988 — Surrogate Endpoint (SUR): Bone mineral density
Study 31124335 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 31126332 — Predictive Biomarker (PRD): FGFR1 mRNA
Genes: FGFR1; BFGFR; CEK; FGFBR; FLG; FLT2; HBGFR
Study 31126332 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study 31127467 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 31127700 — Safety Biomarker (SAF): BDNF
Study 31130229 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 31133597 — Surrogate Endpoint (SUR): Blood pressure
Study 31135970 — Safety Biomarker (SAF): Human leucocyte antigen
Study 31136607 — Predictive Biomarker (PRD): ALPL mRNA
Genes: ALPL
Study 31136607 — Predictive Biomarker (PRD): SPARC mRNA
Genes: SPARC; ON
Study 31136607 — Predictive Biomarker (PRD): RUNX2 mRNA
Genes: RUNX2; AML3; CBFA1; OSF2; PEBP2A
Study 31138499 — Predictive Biomarker (PRD): GLS mRNA
Genes: GLS; GLS1; KIAA0838
Study 31138588 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 31138805 — Predictive Biomarker (PRD): RB1
Genes: RB; PPP1R130
Study 31139640 — Predictive Biomarker (PRD): EPX mRNA
Genes: EPX; EPER; EPO; EPP
Study 31141631 — Predictive Biomarker (PRD): Chromosome 17p
Study 31142037 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 31142314 — Surrogate Endpoint (SUR): Forced vital capacity
Study 31142503 — Predictive Biomarker (PRD): IL15 mRNA
Genes: IL15
Study 31142507 — Predictive Biomarker (PRD): GLS mRNA
Genes: GLS; GLS1; KIAA0838
Study 31143880 — Predictive Biomarker (PRD): TBXT mRNA
Genes: TBXT; T
Study 31146167 — Safety Biomarker (SAF): miR-375
Genes: MIR375
Study 31146700 — Predictive Biomarker (PRD): CHD7 mRNA
Genes: CHD7; KIAA1416
Study 31147302 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study 31147927 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study 31148336 — Predictive Biomarker (PRD): RIPK3 mRNA
Genes: RIPK3; RIP3
Study 31151409 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study 31151904 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study 31151904 — Predictive Biomarker (PRD): KIAA1549 mRNA
Genes: KIAA1549
Study 31152037 — Predictive Biomarker (PRD): Coagulation factor VIII
Genes: F8; F8C
Study 31154041 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study 31154457 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 31154457 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 31154634 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 31154919 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 31155932 — Predictive Biomarker (PRD): LMNA mRNA
Genes: LMNA; LMN1
Study 31156861 — Surrogate Endpoint (SUR): Blood pressure
Study 31156861 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 31157746 — Predictive Biomarker (PRD): Multidrug resistance protein 1
Genes: ABCB1; MDR1; PGY1
Study 31157746 — Surrogate Endpoint (SUR): Blood pressure
Study 31159802 — Predictive Biomarker (PRD): STC2 mRNA
Genes: STC2
Study 31159817 — Predictive Biomarker (PRD): SREBF1 mRNA
Genes: SREBF1; BHLHD1; SREBP1
Study 31159873 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study 31160383 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 31160680 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study 31161734 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 31163675 — Predictive Biomarker (PRD): SLC12A3 mRNA
Genes: SLC12A3; NCC; TSC
Study 31164347 — Predictive Biomarker (PRD): MAX mRNA
Genes: MAX; BHLHD4
Study 31164456 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 31164456 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 31167802 — Predictive Biomarker (PRD): MDM2 mRNA
Genes: MDM2
Study 31167802 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34